Status:
COMPLETED
Evaluating of the Impact of a Connected and Non-intrusive Device in Improving the Screening of Sleep Apnea Syndrome and the Addressing of Potentially Pathological Patients in Hospital Environment
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Sleep Apnea Syndromes
Metabolic Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Diabetes, obesity and metabolic syndrome are closely linked to sleep apnea syndrome. Indeed, diabetic and/or obese patients present an increased risk of sleep apnoea syndrome (SAS), with a prevalence ...
Detailed Description
There is therefore an under-referral of diabetic patients to treatment, perhaps linked to the way care is organized, which clogs up the circuit and slows down or even prevents access to care. The inve...
Eligibility Criteria
Inclusion
- Adult patients over 18 years old
- Diabetes Mellitus (Type 1 or 2), or obesity (BMI\>30kg/m²) or metabolic syndrome
- Hospitalized for at least one night in the Endocrinology department
- Affiliated or entitled to a social security scheme
- Having received informed information about the study and having co-signed, with the investigator, the informed consent form for participation in the study
Exclusion
- Known and/or treated OSAS-type respiratory pathology
- No signature of the informed consent form
- Minor or adult patients under guardianship or curatorship
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 9 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06141967
Start Date
November 30 2023
End Date
July 9 2025
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Saint-Etienne
Saint-Etienne, France, 42055